Atherosclerosis (Q92668803)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31420554%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

review article

1 reference

title

Atherosclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31420554%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Peter Libby

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31420554%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Lina Badimon

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31420554%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Göran K Hansson

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31420554%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Márcio Sommer Bittencourt

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31420554%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Lale Tokgözoğlu

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31420554%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

Eldrin F Lewis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31420554%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

publication date

16 August 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31420554%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Disease Primers

1 May 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31420554%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31420554%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31420554%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

page(s)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31420554%20AND%20SRC:MED&resulttype=core&format=json

Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015

1 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Epidemiology of Atherosclerosis and the Potential to Reduce the Global Burden of Atherothrombotic Disease.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Global and regional patterns in cardiovascular mortality from 1990 to 2013.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

A century of cholesterol and coronaries: from plaques to genes to statins

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

The forgotten majority: unfinished business in cardiovascular risk reduction

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Long-term Safety and Efficacy of Achieving Very Low Levels of Low-Density Lipoprotein Cholesterol : A Prespecified Analysis of the IMPROVE-IT Trial

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Longitudinal and secular trends in total cholesterol levels and impact of lipid-lowering drug use among Norwegian women and men born in 1905-1977 in the population-based Tromsø Study 1979-2016.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Twenty-Five Year Secular Trends in Lipids and Modifiable Risk Factors in a Population-Based Biracial Cohort: The Coronary Artery Risk Development in Young Adults (CARDIA) Study, 1985-2011

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

The immunology of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Immune effector mechanisms implicated in atherosclerosis: from mice to humans

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Adaptive Response of T and B Cells in Atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Triglycerides on the rise: should we swap seats on the seesaw?

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Angiotensin II activates the proinflammatory transcription factor nuclear factor-kappaB in human monocytes

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Inflammation, immunity, and hypertensive end-organ damage

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Obesity, inflammation, and atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Body fat distribution and risk of cardiovascular disease: an update

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Leukocytes Link Local and Systemic Inflammation in Ischemic Cardiovascular Disease: An Expanded "Cardiovascular Continuum".

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Inflammation, Immunity, and Infection in Atherothrombosis: JACC Review Topic of the Week

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

A Test in Context: High-Sensitivity C-Reactive Protein

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Immune-mediated mechanisms of atherosclerosis and implications for the clinic

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Novel features of nitric oxide, endothelial nitric oxide synthase, and atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Endothelial Cell Dysfunction and the Pathobiology of Atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Role of endothelial shear stress in the natural history of coronary atherosclerosis and vascular remodeling: molecular, cellular, and vascular behavior

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Vascular Smooth Muscle Cells in Atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Local proliferation dominates lesional macrophage accumulation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Neuroimmune guidance cue Semaphorin 3E is expressed in atherosclerotic plaques and regulates macrophage retention

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

The ins and outs of inflammatory cells in atheromata

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Inflammation and immunity in diseases of the arterial tree: players and layers

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Transforming growth factor-β signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Vascular smooth muscle cell apoptosis induces interleukin-1-directed inflammation: effects of hyperlipidemia-mediated inhibition of phagocytosis.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Recent insights into the cellular biology of atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular Disease.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

CHIP (Clonal Hematopoiesis of Indeterminate Potential)

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Cardiovascular calcification: current controversies and novel concepts.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Zooming in on the genesis of atherosclerotic plaque microcalcifications

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

The impact of calcification on the biomechanical stability of atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Identifying active vascular microcalcification by (18)F-sodium fluoride positron emission tomography.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Genetic inactivation of IL-1 signaling enhances atherosclerotic plaque instability and reduces outward vessel remodeling in advanced atherosclerosis in mice

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Mechanisms of acute coronary syndromes and their implications for therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Mechanisms of plaque formation and rupture.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic disease

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Thrombosis: tangled up in NETs

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Roles of PAD4 and NETosis in Experimental Atherosclerosis and Arterial Injury: Implications for Superficial Erosion

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Neutrophil Extracellular Traps Induce Endothelial Cell Activation and Tissue Factor Production Through Interleukin-1α and Cathepsin G

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Regulation of the fibrinolytic system of cultured human vascular endothelium by interleukin 1.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Time-Dependent Changes in Atherosclerotic Plaque Composition in Patients Undergoing Carotid Surgery

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Mechanisms of erosion of atherosclerotic plaques.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

TLR2 and neutrophils potentiate endothelial stress, apoptosis and detachment: implications for superficial erosion

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Flow Perturbation Mediates Neutrophil Recruitment and Potentiates Endothelial Injury via TLR2 in Mice: Implications for Superficial Erosion.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Prevalence, Vascular Distribution, and Multiterritorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Promoting Appropriate Use of Cardiac Imaging: No Longer an Academic Exercise

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Effects of coronary stenoses on coronary flow reserve and resistance.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ischemic heart disease

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Coronary Plaque Disruption

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Nonobstructive coronary artery disease and risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by repres

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Implications of Coronary Artery Calcium Testing Among Statin Candidates According to American College of Cardiology/American Heart Association Cholesterol Management Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis).

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Long-term impact on healthcare resource utilization of statin treatment, and its cost effectiveness in the primary prevention of cardiovascular disease: a record linkage study

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Prediction of Lifetime Risk for Cardiovascular Disease by Risk Factor Burden at 50 Years of Age

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Adiposity and cardiovascular risk factors in a large contemporary population of pre-pubertal children

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Maternal and child undernutrition: consequences for adult health and human capital

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Childhood adiposity, adult adiposity, and cardiovascular risk factors.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Family-Based Approaches to Cardiovascular Health Promotion

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Mendelian randomization studies: using naturally randomized genetic data to fill evidence gaps

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Ideal cardiovascular health in adolescence: effect of lifestyle intervention and association with vascular intima-media thickness and elasticity (the Special Turku Coronary Risk Factor Intervention Project for Children [STRIP] study).

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Arterial structure and function after recovery from the metabolic syndrome: the cardiovascular risk in Young Finns Study.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Treatment of periodontitis and endothelial function

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Association between chronic immune-mediated inflammatory diseases and cardiovascular risk.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Intensive periodontal therapy and type 2 diabetes - Authors' reply

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Distribution of 10-year and lifetime predicted risks for cardiovascular disease in US adults: findings from the National Health and Nutrition Examination Survey 2003 to 2006

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Prevalence and progression of subclinical atherosclerosis in younger adults with low short-term but high lifetime estimated risk for cardiovascular disease: the coronary artery risk development in young adults study and multi-ethnic study of atheros

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Online self-assessment of cardiovascular risk using the Joint British Societies (JBS3)-derived heart age tool: a descriptive study

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3).

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Effectiveness of the Heart Age tool for improving modifiable cardiovascular risk factors in a Southern European population: a randomized trial

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Midlife hypertension and 20-year cognitive change: the atherosclerosis risk in communities neurocognitive study

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Cardiovascular Risk Factors From Childhood and Midlife Cognitive Performance: The Young Finns Study

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease: Shared Decision Making in Clinical Practice

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Aspirin for Primary Prevention of Atherosclerotic Cardiovascular Disease: Advances in Diagnosis and Treatment

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Weighing the Anti-Ischemic Benefits and Bleeding Risks from Aspirin Therapy: a Rational Approach

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Should Aspirin Be Used for Primary Prevention in the Post-Statin Era?

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

The rise and fall of aspirin in the primary prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Glucose control and vascular complications in veterans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Interpretation of the evidence for the efficacy and safety of statin therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

What works and in whom? A simple, easily applied, evidence-based approach to guidelines for statin therapy

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Major lipids, apolipoproteins, and risk of vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Combination lipid therapy in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Ezetimibe: an update on its clinical usefulness in specific patient groups

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Efficacy and safety of alirocumab in reducing lipids and cardiovascular events

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Efficacy and safety of evolocumab in reducing lipids and cardiovascular events.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Inclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

'Highest risk-highest benefit' strategy: a pragmatic, cost-effective approach to targeting use of PCSK9 inhibitor therapies.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Association of Aspirin Use for Primary Prevention With Cardiovascular Events and Bleeding Events

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

CardioPulse: 'Ten Commandments' of 2015 European Society of Cardiology Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation (NSTE-ACS)

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Low-Dose Methotrexate for the Prevention of Atherosclerotic Events

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Prostaglandins and inflammation

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Long-term persistence in use of statin therapy in elderly patients

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Impact of postdischarge statin withdrawal on long-term outcomes in patients with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Continued Statin Prescriptions After Adverse Reactions and Patient Outcomes: A Cohort Study.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Assessment of quality of life in severe heart failure

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Assessing quality-of-life outcomes in cardiovascular clinical research

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Narrative review of health-related quality of life and its predictors among patients with coronary heart disease.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Impact of cardiovascular events on change in quality of life and utilities in patients after myocardial infarction: a VALIANT study (valsartan in acute myocardial infarction).

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Racial differences in the association between self-rated health status and objective clinical measures among participants in the BARI 2D trial

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Trajectories of Health-Related Quality of Life in Coronary Artery Disease

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Validity and reliability of three commonly used quality of life measures in a large European population of coronary heart disease patients

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

A brief self-administered questionnaire to determine functional capacity (The Duke Activity Status Index)

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

The PHQ-9: validity of a brief depression severity measure

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Quality of life after coronary artery bypass graft surgery versus percutaneous coronary intervention: what do the trials tell us?

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

High-intensity interval training versus moderate-intensity continuous training on exercise capacity and quality of life in patients with coronary artery disease: A systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Randomized trials of nursing interventions for secondary prevention in patients with coronary artery disease and heart failure: systematic review

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

The association between self-reported lifestyle changes and health-related quality of life in coronary patients: the EUROASPIRE III survey

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

Reassessing the Mechanisms of Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1038%2FS41572-019-0106-Z

7 January 2021

10.1038/S41572-019-0106-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31420554%20AND%20SRC:MED&resulttype=core&format=json

1 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31420554%20AND%20SRC:MED&resulttype=core&format=json